0001562180-24-000399.txt : 20240109
0001562180-24-000399.hdr.sgml : 20240109
20240109210902
ACCESSION NUMBER: 0001562180-24-000399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones David Scott
CENTRAL INDEX KEY: 0001779458
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24524735
MAIL ADDRESS:
STREET 1: C/O EYEPOINT PHARMACEUTICALS, INC.,
STREET 2: 480 PLEASANT STREET, SUITE A210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-05
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001779458
Jones David Scott
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
false
true
false
false
SVP & Chief Commercial Officer
false
Common Stock
2024-01-06
4
M
false
15285.00
0.00
A
42109.00
D
Common Stock
2024-01-06
4
F
false
4147.00
20.40
D
37962.00
D
Restricted Stock Units
0.00
2024-01-05
4
A
false
21000.00
0.00
A
2034-01-05
Common Stock
21000.00
21000.00
D
Stock Option (Right to Buy)
20.40
2024-01-05
4
A
false
42000.00
0.00
A
2034-01-04
Common Stock
42000.00
42000.00
D
Restricted Stock Units
0.00
2024-01-06
4
M
false
15285.00
0.00
D
2033-06-19
Common Stock
15285.00
30570.00
D
Includes 1,691 shares acquired on July 31, 2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.
The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.
The restricted stock units vests in three ratable annual installments beginning January 6, 2024.
/s/ Ron Honig, Attorney-in-Fact
2024-01-09